SYRE: Combination antibody therapies in autoimmune diseases advance toward pivotal global trials
Focused on advancing combination antibody therapies for autoimmune diseases, the pipeline targets IBD, rheumatology, and dermatology, with global trials and a strong financial position. Key readouts this year and next will guide phase III priorities, aiming for products that outperform current stan…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.